Avantor, Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technology industries, announced that Michael Stubblefield intends to step down from his role as Director, President and Chief Executive Officer upon the appointment of a successor. The Board and Mr. …
Gentuity, LLC, a leader in intravascular High Frequency Optical Coherence Tomography (HF-OCT) imaging technology, is pleased to announce the strategic expansion of its senior leadership team with the addition of three highly accomplished professionals: Jason Rudy, Raj Kasbekar, and Alex Yildizyan. These key appointmen…
EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, announced the appointment of Clare Murray, Ph.D., as Chief Executive Officer. Dr. Murray brings deep experience in corporate strategy and business development, having led multiple transactions with glo…
Duke-NUS Medical School has appointed Professor Patrick Tan as its next and fourth Dean, effective 1 January 2026, marking a new chapter for the School as it builds on its legacy of medical education, research and innovation. Prof Tan will serve as Dean-designate from 1 July 2025, succeeding Professor Thomas Coffman, …
CellBio Scientific, a leading global provider of advanced tools and services for biomedical research and preclinical discovery, is excited to announce the appointment of Charles Miller as Chief Executive Officer, effective March 31, 2025. Dr. Miller will lead the company's growth following recent strategic acquisition…
Alcanza Clinical Research, a mission-focused investigator site network dedicated to reducing barriers to clinical research participation, announces the appointment of Karim Chalhoub as President and Chief Operating Officer, and Jeff Irving as Chief Financial Officer. The appointments underscore Alcanza's commitment t…
NeoGenomics, Inc. a leading oncology testing services company, announced that Tony Zook has officially assumed the role of Chief Executive Officer. “Tony has a strong command of the healthcare landscape and a deep understanding of the opportunities ahead for NeoGenomics,” said Lynn Tetrault, Chair of the Board. “His …
Ascential Medical & Life Sciences, a leader in end-to-end solutions for complex medical and life science devices that provides total commercialization services from ideation to scaled manufacturing, today announced three key executive leadership changes that will play an integral role in positioning the company fo…
PrepMD, a leader in cardiac healthcare solutions, has appointed Matt Wilson as Chief Executive Officer (CEO). Wilson's leadership has been instrumental in expanding PrepMD's device clinic management solutions and driving growth through advanced technology and services, with a focus on enhancing patient care and client…
Sage Therapeutics, Inc. announced that Dr. Laura Gault, Chief Medical Officer, has decided to pursue a new opportunity and will depart the Company, effective March 21, 2025. Dr. Gault joined Sage Therapeutics in November 2022 and has led the Company’s product pipeline through all stages of development. Mike Quirk, Chi…
Page 12 of 14